Australia Stock Exchange release from ANTERIS TECH : Successful Interim Results for the First-In-Human Trial
23/01/2022 22:59
Australia Stock Exchange release from ANTERIS TECH AVR.AX : Successful Interim Results for the First-In-Human Trial
Recent news on Anteris Technologies
See all newsBrief: Anteris Technologies Global Corp Gets French Regulatory Clearance For Duravr Paradigm Global Pivotal Trial
Anteris Technologies up as brokerages initiate coverage post-research quiet period
Brief: Anteris Technologies Says Aggregate Gross Proceeds From Offering Was $88.8 Mln
Anteris Technologies slides in Nasdaq debut after $89 mln US IPO
Brief: Anteris Technologies Prices 14.8 Mln Shares At $6.00 Per Share for U.S. IPO